232 related articles for article (PubMed ID: 21217081)
1. Quality-of-life measurement in randomized clinical trials in breast cancer: an updated systematic review (2001-2009).
Lemieux J; Goodwin PJ; Bordeleau LJ; Lauzier S; Théberge V
J Natl Cancer Inst; 2011 Feb; 103(3):178-231. PubMed ID: 21217081
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality-of-life measurement in randomized clinical trials in breast cancer--taking stock.
Goodwin PJ; Black JT; Bordeleau LJ; Ganz PA
J Natl Cancer Inst; 2003 Feb; 95(4):263-81. PubMed ID: 12591983
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Effects of Adjuvant Endocrine Therapy on the Quality of Life of Post-menopausal Women with Non-metastatic ER+ Breast Cancer: A Systematic Review.
Xiao H; Jiang X; Chen C; Montero AJ; Diaby V
Pharmacoecon Open; 2018 Dec; 2(4):359-369. PubMed ID: 29470807
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
7. Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018.
Marandino L; De Luca E; Zichi C; Lombardi P; Reale ML; Pignataro D; Di Stefano RF; Ghisoni E; Mariniello A; Trevisi E; Leone G; Muratori L; La Salvia A; Sonetto C; Buttigliero C; Tucci M; Aglietta M; Novello S; Scagliotti GV; Perrone F; Di Maio M
Clin Genitourin Cancer; 2019 Oct; 17(5):332-347.e2. PubMed ID: 31416754
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series.
Galantino ML; Greene L; Daniels L; Dooley B; Muscatello L; O'Donnell L
Explore (NY); 2012; 8(2):127-35. PubMed ID: 22385567
[TBL] [Abstract][Full Text] [Related]
9. Quality of life of elderly patients with solid tumours undergoing adjuvant cancer therapy: a systematic review.
Cheng KK; Lim EY; Kanesvaran R
BMJ Open; 2018 Jan; 8(1):e018101. PubMed ID: 29371271
[TBL] [Abstract][Full Text] [Related]
10. Reliability, validity and feasibility of quality of life instruments for adult patients with cancer undergoing chemotherapy: result from a systematic review.
Yip WK; Mordiffi SZ; Ang E
Int J Evid Based Healthc; 2012 Mar; 10(1):27-52. PubMed ID: 22405415
[TBL] [Abstract][Full Text] [Related]
11. Quality of life in randomized trials of cytotoxic or hormonal treatment of advanced breast cancer. Is there added value?
Fossati R; Confalonieri C; Mosconi P; Pistotti V; Apolone G
Breast Cancer Res Treat; 2004 Oct; 87(3):233-43. PubMed ID: 15528966
[TBL] [Abstract][Full Text] [Related]
12. Long term effects of extended adjuvant endocrine therapy on quality of life in breast cancer patients.
Kool M; Fontein DB; Meershoek-Klein Kranenbarg E; Nortier JW; Rutgers EJ; Marang-van de Mheen PJ; van de Velde CJ
Breast; 2015 Jun; 24(3):224-9. PubMed ID: 25704982
[TBL] [Abstract][Full Text] [Related]
13. Weight gain and quality of life in women treated with adjuvant chemotherapy for early-stage breast cancer.
McInnes JA; Knobf MT
Oncol Nurs Forum; 2001 May; 28(4):675-84. PubMed ID: 11383182
[TBL] [Abstract][Full Text] [Related]
14. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.
Shaitelman SF; Schlembach PJ; Arzu I; Ballo M; Bloom ES; Buchholz D; Chronowski GM; Dvorak T; Grade E; Hoffman KE; Kelly P; Ludwig M; Perkins GH; Reed V; Shah S; Stauder MC; Strom EA; Tereffe W; Woodward WA; Ensor J; Baumann D; Thompson AM; Amaya D; Davis T; Guerra W; Hamblin L; Hortobagyi G; Hunt KK; Buchholz TA; Smith BD
JAMA Oncol; 2015 Oct; 1(7):931-41. PubMed ID: 26247543
[TBL] [Abstract][Full Text] [Related]
15. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
National Institutes of Health Consensus Development Panel
J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonates for breast cancer.
Pavlakis N; Stockler M
Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
[TBL] [Abstract][Full Text] [Related]
17. Assessment of quality of life during chemotherapy.
Gunnars B; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):175-84. PubMed ID: 11441930
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]